Lymph stasis promotes tumor growth

Journal of Dermatological Science

Volumn 90, Issue 3, 2018, Pages 366-367

  De Vita, Valerio ^a   Ruocco, Eleonora ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH; DISEASE ASSOCIATION; HUMAN; IMMUNOPATHOLOGY; LETTER; LYMPHEDEMA; PRIORITY JOURNAL; SKIN CANCER;

EID: 85046812228     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2018.02.010     Document Type: Letter

References (12)

1. Nakamura, Y., Fujisawa, Y., Okiyama, N., Watanabe, R., Tanaka, R., Ishitsuka, Y., Tahara, H., Fujimoto, M., Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response. J. Dermatol. Sci., 2017, 10.1016/j.jdermsci.2017.12.016.
2. Ruocco, V., Schwartz, R.A., Ruocco, E., Lymphedema: an immunologically vulnerable site for development of neoplasms. J. Am. Acad. Dermatol. 47 (2002), 124–127.
3. Ruocco, E., Puca, R.V., Brunetti, G., Schwartz, R.A., Ruocco, V., Lymphedematous areas: privileged sites for tumors, infections, and immune disorders. Int. J. Dermatol., 46, 2007, 662.
4. Ruocco, V., Brunetti, G., Puca, R.V., Ruocco, E., The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites. J. Eur. Acad. Dermatol. Venereol. 23 (2009), 1364–1373.
5. Ruocco, V., Ruocco, E., Brunetti, G., Sangiuliano, S., Wolf, R., Opportunistic localization of skin lesions on vulnerable areas. Clin. Dermatol. 29 (2011), 483–488.
6. Ruocco, V., Ruocco, E., Piccolo, V., et al. The immunocompromised district in dermatology: a unifying pathogenic view of the regional immune dysregulation. Clin. Dermatol. 32 (2014), 569–576.
7. Grada, A.A., Phillips, T.J., Lymphedema: pathophysiology and clinical manifestations. J. Am. Acad. Dermatol. 77 (2017), 1009–1020.
8. Fabbrocini, G., Ruocco, E., De Vita, V., Monfrecola, G., Squamous cell carcinoma arising in long-standing hidradenitis suppurativa: an overlooked facet of the immunocompromised district. Clin. Dermatol. 35 (2017), 225–227.
9. De Vita, V., Ruocco, E., Letter to the Editor referring to Hessam et al. -Squamous cell carcinoma arising in hidradenitis suppurativa: subclinical lymphedema may have favored the tumor onset. J. Dtsch. Dermatol. Ges. 15 (2017), 580–582.
10. De Vita, V., Ruocco, E., The concept of immunocompromised district might explain the carcinogenic progression in hidradenitis suppurativa. Acta. Oncol. 56 (2017), 1330–1331.
11. De Vita, V., Ruocco, E., Mucinous adenocarcinoma in association with hidradenitis suppurativa: a new example of isoscartopic response. Clin. Exp. Dermatol., 2017, 10.1111/ced.13338.
12. Piccolo, V., Baroni, A., Russo, T., Schwartz, R.A., Ruocco's immunocompromised cutaneous district. Int. J. Dermatol. 55 (2016), 135–141.